Edgen Stock·Sep 18 2025, 20:13戻る
AllRock Bio Secures $50 Million Series A Funding for Pulmonary Hypertension Drug Development
Edgen Stock·Sep 18 2025, 20:13
[1] Former CinCor execs reunite to helm new biotech startup (https://www.biopharmadive.com/news/allrock-bi ...)[2] CinCor team reunites at AllRock with $50M to advance another hypertension drug (https://www.endpointsnews.com/news/cincor-tea ...)[3] AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension - BioSpace (https://www.biospace.com/article/releases/all ...)
